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ABSTRACT 
 
Autoimmune polyendocrine syndrome type 1 (APS1) is a scarce polyendocrinopathy with 
autosomal recessive inheritance results from defects in the human autoimmune regulatory 
(AIRE) gene. In addition to three major manifestations of APS1 including mucocutaneous 
candidiasis, hypoparathyroidism, and Addison’s disease, ophthalmic problems such as 
keratoconjunctivitis, dry eye, iridocyclitis, and cataract can be seen in these patients. In this 
article, we introduced two siblings presented with nail dystrophia, severe photophobia, and 
keratitis since early childhood which genetic examination revealed single nucleotide T>C 
translocation in their 2nd exon and heterozygous deletion mutation in their 12th exon.  
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INTRODUCTION 
 
Autoimmune polyglandular syndrome type 1 
(APS1) is considered as a scarce and complex disease 
associated with the incidence of fewer than 1/100 000 
people per year.
1 
It is developed as a result of an 
autosomal recessive inheritance and mutations in the 
autoimmune regulator (AIRE) gene which involves 
different endocrine and non-endocrine organs.
2  
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Patients with APS 1 have a type of primary 
immunodeficiency accompanying chronic 
mucocutaneous candidiasis.
3 
T regulatory (Treg)-cell 
defects can interrupt immunologic tolerance in the 
body, leading to autoimmune diseases.
4
 The presence 
of auto-antibodies to interleukin (IL)-17, IL-22, and 
Type I interferon is regarded as immunological 
disorders.
3
 There are three major symptoms including 
mucocutaneous candidiasis, hypoparathyroidism, and 
Addison disease that are used to diagnose APS 1.
5
 
Moreover, other manifestations (such as 
hypergonadotropic hypogonadism, autoimmune thyroid 
diseases, keratoconjunctivitis, and lymphocytic 
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hypophysitis), with less frequency are developed in 
patients with APS1.
6
 Herein we present two siblings 
with ophthalmic manifestations since early childhood. 
 
CASE PRESENTATION 
 
A 5-year-old girl was referred to the immunology 
department in Children’s Medical Center with a history 
of severe photophobia that forced her to close her eyes 
in the light. She had been diagnosed by an 
ophthalmologist to have severe limbal stem cell 
deficiency (LSCD) and keratitis when she was about 
the age of 30-month. Informed consent was obtained 
from the parents of patients. This study was approved 
by the Ethics Committee of Tehran University of 
Medical Sciences (N: 1395.1923). 
Her brother had also been referred with 
conjunctivitis, light sensitivity, and dry eye when he 
was 9.5-year-old. Moreover; he had been diagnosed to 
have severe LSCD and keratitis by the ophthalmologist 
between ages 2 and 3. He additionally had four distinct 
depigmented skin lesions that started at the age of 7 
which diagnosed as vitiligo. 
Both siblings had a history of prolonged oral 
candidiasis. They were born as term neonates via 
normal vaginal delivery. Separation of their umbilical 
cords had occurred during the first two weeks of life. 
Nail dystrophy was also observed in their mother  
and their older brother. They didn’t show other 
symptoms of this disease. All tests related to organs 
and glands involvement were normal. There were 5 
deaths without known causes in their mother’s family 
in their first year of life. 
In the physical examination, the boy had normal 
weight and height. He closed his eyes in the light, and 
there was one 2×1.5 cm hair loss area on his skull and 
four depigmented lesions were observed on the skin of 
his abdomen, neck, and face. Apart from those 
findings, his physical examination showed  
keratitis, photosensitivity, and all hand and foot nails 
dystrophia. The negative result was obtained after 
evaluating nails for fungal infection. 
Both siblings were referred from the endocrinology 
department with the diagnosis of probably Sjogren 
syndrome and admitted at the hospital for thorough 
diagnostic evaluation. After immunologic evaluations, 
both of them developed diarrhea and vomiting, 
weakness, and hypotension. 
 
 
Figure 1. The family pedigree of two siblings with severe ocular problems and 
autoimmune polyglandular syndrome 
 
 
 
 
 
 
 
Adrenal glands functions were evaluated by checking 
serum level of cortisol, adrenocorticotropic hormone 
(ACTH), glucose, calcium, phosphorus, and magnesium. 
Finally, based on the obtained results, the diagnosis of 
adrenal insufficiency was proved (Table 1). 
Given the co-existence of different autoimmune 
manifestations including hypoadrenalism, 
hypoparathyroidism, and ocular manifestations as well 
as nail dystrophy in patients and their family and 
consanguinity of their parents, a genetic assessment 
was done to rule in an inherited disorder with clinical 
suspicion of APS 1. Genetic examination of the AIRE 
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gene using Sanger sequencing revealed single 
nucleotide T>C translocation in their 2nd exon with the 
displacement of tryptophan by arginine and deletion 
mutation in their 12th exon. Their mother and father 
were the carrier of the mutated gene, but no mutation 
was found in their old brother (Figure 1). 
 
Table 1. Patients' laboratory findings 
Laboratory data The sister (5 y) The brother (9.5y) Normal Range 
White blood cells (/µL) 
Neutrophils (%) 
Eosinophils (%) 
Lymphocytes (%) 
Monocytes (%) 
8.48×103 
45 
4 
45 
6 
8.13×103 
48 
5 
37 
10 
4-10×103 
50-70 
0.5-5.0 
20-40 
3.0-8.0 
Hemoglobin(g/dL) 
Hemoglobin A1c 
11.7 
5.7 
12.6 
5.5 
12.0-15.0 
<5.7 
Platelet (/µL) 348×103 343× 103 150-410×103 
BUN (mg/dL) 
Creatinine (mg/dL) 
Serum calcium (mg/dL) 
Serum phosphor (mg/dL) 
Serum magnesium (mEq/L) 
Sodium (mEq/L) 
Potassium (mEq/L) 
Blood sugar(mg/dL) 
PTH (pg/mL) 
ACTH (pg/mL) 
Cortisol (µg/dL) 
25 
0.8 
5.7 
7.4 
1.5 
126 
4.8 
78 
5 
360 
8 
20 
0.5 
10 
4.8 
2 
115 
4.7 
97 
18 
457 
4 
 
5-20 
0.3-0.7 
8.6-10.3 
3-4.5 
1.5-2.4 
135-145 
3.5-5.1 
70-105 
12-88 
10-60 
10-20 
 
25-OH Vitamine D3 (ng/mL) 11 15 20-70 
T4 (µg/dL) 
TSH (mIU/mL) 
7 
0.5 
10 
2.5 
4.8-11.6 
0.39-5.95 
Anti TTG 25 (Negative) 42 (Negative)  
Anti TPO 27 (Negative) 65 (Positive)  
Immunoglobulin G (mg/dL) 
Immunoglobulin A (mg/dL) 
Immunoglobulin M (mg/dL) 
Immunoglobulin E (IU/mL) 
1281 
173 
200 
0 
943 
106 
184 
9 
*(463-1236), (608-1572) 
*(25-154), (45-236) 
*(43-196), (52-242) 
*(1.07-68.9), (0.98-570.6) 
CD3 (/µL) 
CD4 (/µL) 
CD8(/µL) 
CD19 (/µL) 
CD16 (/µL) 
CD56 (/µL) 
2289 
1640 
610 
1526 
114 
114 
2165 
1443 
421 
661 
15 
15 
*(1400-3700), (1200-2600) 
*(700- 2200), (650-1500) 
*(490-1300),(370-1100) 
*(390-1400), (270-860) 
 
Tuberculin skin test Negative (<5 mm  
induration) 
Negative (<5mm 
induration) 
 
FANA 1/160 (Negative) 1/320 (Negative)  
Anti-dsDNA 3 ( <100 Negative) 3  
*Age-related normal range of Immunoglobulins and lymphocyte subsets were obtained from The Harriet Lane Handbook.Huges HK, Kahl LK. 
Twenty-first Edition. BUN (Blood urea nitrogen); PTH (Parathyroid hormone); ACTH (Adrenocorticotropic hormone); TSH (Thyroid-stimulating 
hormone); Anti- TTG (Anti-tissue transglutaminase); Anti TPO Ab (Anti-thyroid peroxidase antibodies); FANA (Fluorescent 
antinuclear antibody test ). 
 
 
Both had taken fludrocortisone, hydrocortisone, and dextrose saline for this problem, and electrolyte 
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imbalance were corrected. The girl had a low serum 
level of calcium and received intravenous calcium 
gluconate 10%. Both were put on Vitamin D3 
supplement for Vitamin D insufficiency. Both received 
Rituximab 375 mg/m2 dose two times to treat the 
keratoconjunctivitis and their photophobia got better 
after two weeks. Finally, they were referred to an 
ophthalmologist for the management of LSCD. 
 
DISCUSSION 
 
Herein we described two siblings referred to our 
hospital with nail dystrophia, photophobia, keratitis, 
and LSCD. Following a physical examination and 
immunologic evaluations, we found vitiligo, alopecia, 
chronic mucocutaneous candidiasis, 
hypoparathyroidism, autoimmune thyroiditis, and 
adrenal insufficiency with a genetically confirmed 
diagnosis of APS 1.  
Keratoconjunctivitis, dry eyes, iridocyclitis, 
cataract, retinal detachment, and optic atrophy have 
been identified as ocular symptoms in patients with 
APS 1.7 In a review article by Guo et al, candidiasis  
and Keratoconjunctivitis had the most and the fewest 
frequency among clinical symptoms in patients with 
APS between 1990 and 2017.
2 
The potential problem in 
the diagnosis of APS is variation in existence and order 
of the development of clinical features. In our patients, 
ocular manifestations including severe photophobia  
and keratitis manifested as the earliest symptoms at the 
age of about 2.5 years in early childhood. The mere 
focus on the classic manifestations of APS 
(hypoparathyroidism, adrenocortical failure, and 
candidiasis) might lead to delay in the diagnosis and 
consequently the management of the patients.2 In a 
study by Akil et al, evaluation of endocrinal system and 
consideration to the diagnosis of APS type 1 has been 
emphasized in children with visual complications and a 
history of chronic candidiasis and ectodermal 
Dysplasias or hypoparathyroidism.
7
 
Approximately 50% of APS 1 patients suffer from 
disabling keratitis which is known as an important 
characteristic of the disease.8 According to the study of 
Merenmies L et al, two etiological agents to develop 
keratitis in patients with APS 1 could be 
hypoparathyroidism and chronic candidiasis. 
Additionally, about 75% of patients with APS 1 
manifested any symptoms of keratitis in their study.
9  
In the study of Yeh et al on AIRE-deficient mice, the 
important role of immunological processes in the 
development of ocular complications in murine APS 1 
model was considered.10 
In conclusion, APS 1 is considered as a rare 
syndrome with different endocrinopathies and 
autoimmune manifestations. The important point was 
the onset of nail dystrophy in the patients, their  
mother, brother, and uncle as well as ophthalmic 
problems in the patients. The exact clinical history and 
physical examination were very important in these 
cases. Physicians especially endocrinologists, 
ophthalmologists, and clinical immunologists should  
be aware of this syndrome to do the diagnostic 
evaluation at the proper time and start the therapeutic 
measures as soon as possible to improve the patients' 
quality of life and prevent the complications. 
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